As of March 24, 2025, both the FDA and the American Society of Health-System Pharmacists (ASHP) websites have listed branded ...

Glucagon is a hormone that signals the liver to release glucose into the bloodstream. It's typically given by injection to counteract severe hypoglycemia in people who have diabetes. While an ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...

In 24 of the 27 attacks, complete recovery occurred five to thirty minutes after a single intramuscular injection of 1 mg. of glucagon. In the remaining 3 attacks (all in the same patient), there ...

In such cases, they may need to use an emergency glucagon kit. This involves administering medication that can help quickly raise a person’s blood sugar levels. Glucagon is typically available ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and ...

The issuer is solely responsible for the content of this announcement.

Xeris has 3-4 approved products; these are: Gvoke (glucagon injection): Gvoke is the first autoinjector for severe hypoglycemia approved by the FDA. Keveyis (dichlorphenamide): The first FDA ...